Research Article

Polymorphisms in NLRP1 Gene Are Associated with Type 1 Diabetes

Table 5

Clinical characteristics of participants with T1D in different genotypes of SNPs in the NLRP1 gene.

CharacteristicsSNP
rs11651270rs2670660
CCCTTT valueGGGAAA value

Sample size2314534214123373
Sex (men/women)12/1180/65183/1590.9318/670/53197/1760.710
Age of onset (years)29 (13-37)23 (14-33)17 (10-32)0.00127 (15-35)21 (13-35)18 (10-32)0.057
T1D duration (months)4.00 (0.23-24.00)3.00 (0.33-18.00)5.00 (0.56-24.00)0.5900.59 (0.12-6.00)5.00 (0.47-36.00)5.00 (0.50-16.00)0.068
BMI (kg/m2)19.63 (17.94-21.23)18.80 (16.80-20.80)18.51 (16.30-20.70)0.15519.50 (18.52-20.59)18.91 (16.80-21.08)18.60 (16.39-20.67)0.187
FCP (pmol/L)93.64 (4.55-169.75)79.63 (21.18-190.98)74.00 (16.10-156.07)0.602148.60 (53.99-213.88)79.00 (18.89-164.80)73.54 (15.92-158.87)0.184
PCP (pmol/L)169.83 (15.52-259.69)152.81 (47.80-318.66)135.00 (34.90-263.40)0.402220.88 (138.68-369.63)161.30 (40.83-284.34)133.85 (35.94-261.85)0.129
HbA1c (%)10.10 (8.65-14.00)9.75 (7.73-12.48)10.10 (7.70-12.80)0.61112.50 (9.23-14.35)9.70 (7.70-12.50)10.10 (7.70-12.80)0.153
GADA positive%91.30%90.34%87.39%0.58792.86%86.18%88.98%0.611
IA-2A positive%52.38%42.42%48.41%0.44938.46%45.05%47.81%0.726
ZnT8A positive%45.00%25.62%32.12%0.16235.71%25.25%32.46%0.372
GADA titer (U/mL)448.33 (248.47-850.88)328.43 (91.06-788.30)288.81 (78.79-755.57)0.289756.39 (271.01-929.77)266.86 (78.81-728.13)313.80 (82.87-765.60)0.127
IA-2A titer (U/mL)361.12 (62.69-790.02)190.66 (45.07-659.52)186.51 (52.12-663.96)0.61862.69 (28.90-575.57)113.51 (41.42-575.28)231.99 (59.24-695.60)0.143

SNP: single-nucleotide polymorphisms; BMI: body mass index; FCP: fasting C-peptide; PCP: 2 h postprandial C-peptide; HbA1c: glycated hemoglobin; GADA: glutamic acid decarboxylase antibody; IA-2A: protein tyrosine phosphatase antibody; ZnT8A: zinc transporter 8 antibody.